Trending Now
DON'T MISS
A new molecular mechanism could explain the origins of the depressive...
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of...
My Huntington’s disease sister – and a hero who strives for...
Sharon Shaffer is my Huntington’s disease sister – and my hero.
Afflicted with progressively worse HD symptoms the past 15 years, San Diego area resident...
LATEST VIDEOS
TRAVEL GUIDE
Through the eyes of a friend: changes in mood and behavior...
The family and friends of individuals with HD often tell doctors that they began to notice changes in behavior long before a diagnosis was...
High-Resolution Mapping Technique Uncovers Underlying Circuit Architecture of the Brain
Joint Gladstone-Salk study to help scientists decode circuitry that guides brain function
SAN FRANCISCO, CA—June 27, 2013—The power of the brain lies in its trillions of...
PHONES & DEVICES
Details emerge of first Huntington’s disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of...
EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for...
LATEST TRENDS
Mutant Protein Spreads Through a Neural Circuit in Huntington’s Disease
The discovery suggests a new therapeutic strategy for the neurodegenerative disease.
Outbreaks of mad cow disease in the 1980s and 1990s highlighted a seemingly rare...
Failure to Destroy Toxic Protein—not Buildup of Protein Itself—Contributes to Progression...
Gladstone-led study also finds target that boosts protein clearance, prolongs cell life
SAN FRANCISCO, CA—July 21, 2013—Alzheimer’s, Huntington’s, Parkinson’s. Names forever linked to what they represent:...
TECH
FASHION
REVIEWS
Details emerge of first Huntington’s disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...
ENTERTAIMENT
